2010 Annual Meeting
(621f) Can A Design Space Be Built On Material Attributes Alone?
Authors
Michaels, J. N. - Presenter, Merck and Co. Inc.
Bonsignore, H. - Presenter, Pfizer Inc.
Hudson-Curtis, B. L. - Presenter, GlaxoSmithKline
Laurenz, S. - Presenter, Abbott Laboratories
Mathai, T. - Presenter, Cephalon
Pande, G. - Presenter, GlaxoSmithKline
Sheth, A. - Presenter, Merck & Co., Inc.
Sprockel, O. - Presenter, Bristol-Myers Squibb Company
Lin, H. - Presenter, Amgen
In April, 2009, the PhRMA Drug Product Technical Group sponsored an industry workshop to explore the practicality and limitations of defining a design space in terms of material attributes rather than process variables. This presentation summarizes and expands on the output of this workshop. A material-attribute design space would be independent of scale and configuration of process equipment and the associated process variables. For this reason, it would be portable in the sense that post-approval changes of equipment scale, nameplate, or location would not require regulatory approval. A hypothetical case study of an immediate release oral tablet is presented to illustrate how such a design space could be constructed and implemented.